This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vision-Sciences, Inc. Announces Election Of New Director

ORANGEBURG, N.Y., Dec. 15, 2010 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) (Vision-Sciences), announced today that its Board of Directors elected Dr. Bruce Polsky to serve as a member of its Board, effective immediately. Dr. Polsky will be an independent member of the Board.

"I am extremely pleased to welcome Bruce to the Board. His extensive medical background and knowledge of infectious diseases add significantly to our organization," said Lewis Pell, Chairman of Vision-Sciences. Dr. Polsky was elected as a Class II director, to serve until Vision-Sciences' 2011 annual shareholders' meeting. Dr. Polsky was nominated to be reelected to the Board at Vision-Sciences' annual shareholders' meeting, expected to be held in September 2011.

Dr. Polsky commented, "I am delighted to join the Board of Vision-Sciences. I believe the Company's EndoSheath Technology for flexible endoscopy is unique, providing sterile, efficient endoscopic procedures without the traditional complexities and difficulties associated with conventional endoscopy." 

Dr. Polsky built an international reputation as an expert in infectious diseases at Memorial Sloan-Kettering Cancer Center, where he also held the academic title of Associate Professor of Medicine at Cornell University Medical College. Dr. Polsky is currently Chairman of the Department of Medicine, Chief of the Division of Infectious Diseases, Hospital Epidemiologist and Medical Director of the Clinical Virology Laboratory at St. Luke's-Roosevelt Hospital Center in New York City. Dr. Polsky also serves as the John H. Keating Sr. Professor of Clinical Medicine at the College of Physicians and Surgeons of Columbia University. 

Dr. Polsky is a graduate of the University of Michigan and the Wayne State University School of Medicine. His post-graduate training in Internal Medicine was at Montefiore Medical Center and the Albert Einstein College of Medicine in New York City, followed by a fellowship in infectious diseases at Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, where he joined the faculty upon completion of his training in 1986, remaining until 1998. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs